Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapid vs Conventional Chemotherapy for Stage 4 Neuroblastoma
NCT00365755Phase 3Completed
- Sponsor
- Children's Cancer and Leukaemia Group
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
01
Overview
Phase 3, randomised, open-label trial of vincristine, cyclophosphamide, cisplatin, etoposide and carboplatin in neuroblastoma (2 arms), sponsored by Children's Cancer and Leukaemia Group. Primary endpoints: Response rates (bone marrow and primary tumor) and Event-Free Survival. Status: completed.
02
Drugs
vincristinecyclophosphamidecisplatinetoposidecarboplatin
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT00365755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00365755.